x

Search for a clinical trial

* (*) mandatory field

118 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

FRANCE

ILE-DE-FRANCE
PARIS

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
A phase II study of the efficacy and safety of lenalidomide combined to azacitidine in intermediate-2 or high risk MDS AND AML with del 5q (GFM-Aza-Rev-09)
GHU AP-HP Nord. Université de Paris - Hôpital Saint-Louis
Groupe Francophone des Myélodysplasies (GFM)

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
A phase I-II study of the efficacy and safety of idarubicin combined to azacitidine in int-2 or high risk myelodysplastic syndromes.
GHU AP-HP Nord. Université de Paris - Hôpital Saint-Louis
Groupe Francophone des Myélodysplasies (GFM)

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
AZA-PLUS - Randomised phase II trial seeking the most promising drug association with azacitidine in higher risk myelodysplastic syndromes.
GHU AP-HP Nord. Université de Paris - Hôpital Saint-Louis
Service d'Hématologie seniors

FRANCE

ILE-DE-FRANCE
PARIS

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

GERMANY

Baden-Württemberg
FREIBURG

GERMANY

Baden-Württemberg
FREIBURG

GERMANY

Hessen
FRANKFURT AM MAIN

GERMANY

Niedersachsen
HANNOVER

GERMANY

Nordrhein-Westfalen
DÜSSELDORF

GERMANY

Sachsen
LEIPZIG

GERMANY

Sachsen
LEIPZIG

Recruiting trial
Ongoing trial
BERGAMO: A Phase II Study Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes Failing Standard of Care Therapy -DE
Universitätsklinikum Leipzig AöR
Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie

NETHERLANDS

Zuid-Holland
LEIDEN

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ongoing trial
STEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique

Multinational clinical trial(s)

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

GERMANY

Sachsen
LEIPZIG

BERGAMO: A Phase II Study Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes Failing Standard of Care Therapy
Universitätsklinikum Leipzig AöR
Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie